nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycopyrrolate—CHRM4—nervous system—Alzheimer's disease	0.0042	0.0713	CbGeAlD
Glycopyrrolate—CHRM2—forebrain—Alzheimer's disease	0.00415	0.0705	CbGeAlD
Glycopyrrolate—CHRM4—central nervous system—Alzheimer's disease	0.00405	0.0687	CbGeAlD
Glycopyrrolate—CHRM2—telencephalon—Alzheimer's disease	0.00382	0.0648	CbGeAlD
Glycopyrrolate—CHRM1—forebrain—Alzheimer's disease	0.00378	0.0642	CbGeAlD
Glycopyrrolate—Gastroenteritis—Memantine—Alzheimer's disease	0.00368	0.00469	CcSEcCtD
Glycopyrrolate—Hyperglycaemia—Galantamine—Alzheimer's disease	0.00361	0.00461	CcSEcCtD
Glycopyrrolate—Gastroenteritis—Rivastigmine—Alzheimer's disease	0.0036	0.00459	CcSEcCtD
Glycopyrrolate—Pneumonia—Galantamine—Alzheimer's disease	0.00359	0.00458	CcSEcCtD
Glycopyrrolate—Affect lability—Donepezil—Alzheimer's disease	0.00354	0.00451	CcSEcCtD
Glycopyrrolate—CHRM1—telencephalon—Alzheimer's disease	0.00348	0.059	CbGeAlD
Glycopyrrolate—Urinary tract infection—Galantamine—Alzheimer's disease	0.00347	0.00443	CcSEcCtD
Glycopyrrolate—Atrial fibrillation—Memantine—Alzheimer's disease	0.00344	0.00439	CcSEcCtD
Glycopyrrolate—Irritability—Donepezil—Alzheimer's disease	0.00343	0.00437	CcSEcCtD
Glycopyrrolate—Urinary retention—Donepezil—Alzheimer's disease	0.00342	0.00436	CcSEcCtD
Glycopyrrolate—Mood swings—Donepezil—Alzheimer's disease	0.0034	0.00434	CcSEcCtD
Glycopyrrolate—CHRM3—forebrain—Alzheimer's disease	0.00338	0.0574	CbGeAlD
Glycopyrrolate—Epistaxis—Galantamine—Alzheimer's disease	0.00337	0.0043	CcSEcCtD
Glycopyrrolate—Atrial fibrillation—Rivastigmine—Alzheimer's disease	0.00337	0.00429	CcSEcCtD
Glycopyrrolate—Dehydration—Donepezil—Alzheimer's disease	0.00334	0.00426	CcSEcCtD
Glycopyrrolate—Dry skin—Donepezil—Alzheimer's disease	0.00329	0.0042	CcSEcCtD
Glycopyrrolate—CHRM5—nervous system—Alzheimer's disease	0.00328	0.0558	CbGeAlD
Glycopyrrolate—Pain in extremity—Memantine—Alzheimer's disease	0.00326	0.00416	CcSEcCtD
Glycopyrrolate—Rhinitis—Galantamine—Alzheimer's disease	0.00322	0.0041	CcSEcCtD
Glycopyrrolate—Nasopharyngitis—Donepezil—Alzheimer's disease	0.00321	0.0041	CcSEcCtD
Glycopyrrolate—CHRM4—brain—Alzheimer's disease	0.00321	0.0545	CbGeAlD
Glycopyrrolate—Affect lability—Memantine—Alzheimer's disease	0.00321	0.00409	CcSEcCtD
Glycopyrrolate—Pain in extremity—Rivastigmine—Alzheimer's disease	0.00319	0.00407	CcSEcCtD
Glycopyrrolate—Urinary tract disorder—Galantamine—Alzheimer's disease	0.00317	0.00404	CcSEcCtD
Glycopyrrolate—CHRM5—central nervous system—Alzheimer's disease	0.00316	0.0537	CbGeAlD
Glycopyrrolate—Connective tissue disorder—Galantamine—Alzheimer's disease	0.00315	0.00402	CcSEcCtD
Glycopyrrolate—Urethral disorder—Galantamine—Alzheimer's disease	0.00314	0.00401	CcSEcCtD
Glycopyrrolate—Affect lability—Rivastigmine—Alzheimer's disease	0.00314	0.004	CcSEcCtD
Glycopyrrolate—Abdominal distension—Donepezil—Alzheimer's disease	0.00313	0.00399	CcSEcCtD
Glycopyrrolate—Irritability—Memantine—Alzheimer's disease	0.00311	0.00397	CcSEcCtD
Glycopyrrolate—CHRM3—telencephalon—Alzheimer's disease	0.00311	0.0528	CbGeAlD
Glycopyrrolate—Cardiac arrest—Memantine—Alzheimer's disease	0.0031	0.00395	CcSEcCtD
Glycopyrrolate—Urinary retention—Memantine—Alzheimer's disease	0.0031	0.00395	CcSEcCtD
Glycopyrrolate—Mood swings—Memantine—Alzheimer's disease	0.00309	0.00394	CcSEcCtD
Glycopyrrolate—Cardiac arrest—Rivastigmine—Alzheimer's disease	0.00303	0.00387	CcSEcCtD
Glycopyrrolate—Urinary retention—Rivastigmine—Alzheimer's disease	0.00303	0.00387	CcSEcCtD
Glycopyrrolate—Dehydration—Memantine—Alzheimer's disease	0.00303	0.00387	CcSEcCtD
Glycopyrrolate—Mood swings—Rivastigmine—Alzheimer's disease	0.00302	0.00385	CcSEcCtD
Glycopyrrolate—Dry skin—Memantine—Alzheimer's disease	0.00299	0.00381	CcSEcCtD
Glycopyrrolate—Abdominal discomfort—Donepezil—Alzheimer's disease	0.00298	0.00379	CcSEcCtD
Glycopyrrolate—Cardiac disorder—Galantamine—Alzheimer's disease	0.00298	0.00379	CcSEcCtD
Glycopyrrolate—Flushing—Galantamine—Alzheimer's disease	0.00298	0.00379	CcSEcCtD
Glycopyrrolate—Dehydration—Rivastigmine—Alzheimer's disease	0.00297	0.00378	CcSEcCtD
Glycopyrrolate—Dry skin—Rivastigmine—Alzheimer's disease	0.00293	0.00373	CcSEcCtD
Glycopyrrolate—Nasopharyngitis—Memantine—Alzheimer's disease	0.00292	0.00372	CcSEcCtD
Glycopyrrolate—Dysuria—Donepezil—Alzheimer's disease	0.0029	0.0037	CcSEcCtD
Glycopyrrolate—Nasopharyngitis—Rivastigmine—Alzheimer's disease	0.00285	0.00364	CcSEcCtD
Glycopyrrolate—Mental disorder—Galantamine—Alzheimer's disease	0.00281	0.00358	CcSEcCtD
Glycopyrrolate—Hyperglycaemia—Donepezil—Alzheimer's disease	0.0028	0.00357	CcSEcCtD
Glycopyrrolate—Malnutrition—Galantamine—Alzheimer's disease	0.00279	0.00356	CcSEcCtD
Glycopyrrolate—Pneumonia—Donepezil—Alzheimer's disease	0.00278	0.00355	CcSEcCtD
Glycopyrrolate—Infestation—Donepezil—Alzheimer's disease	0.00277	0.00353	CcSEcCtD
Glycopyrrolate—Infestation NOS—Donepezil—Alzheimer's disease	0.00277	0.00353	CcSEcCtD
Glycopyrrolate—Flatulence—Galantamine—Alzheimer's disease	0.00275	0.00351	CcSEcCtD
Glycopyrrolate—Tension—Galantamine—Alzheimer's disease	0.00274	0.00349	CcSEcCtD
Glycopyrrolate—Dysgeusia—Galantamine—Alzheimer's disease	0.00273	0.00349	CcSEcCtD
Glycopyrrolate—Nervousness—Galantamine—Alzheimer's disease	0.00271	0.00346	CcSEcCtD
Glycopyrrolate—Urinary tract infection—Donepezil—Alzheimer's disease	0.00269	0.00343	CcSEcCtD
Glycopyrrolate—Sweating—Donepezil—Alzheimer's disease	0.00265	0.00338	CcSEcCtD
Glycopyrrolate—Dysuria—Memantine—Alzheimer's disease	0.00264	0.00336	CcSEcCtD
Glycopyrrolate—Vision blurred—Galantamine—Alzheimer's disease	0.00263	0.00335	CcSEcCtD
Glycopyrrolate—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.00262	0.00334	CcSEcCtD
Glycopyrrolate—Epistaxis—Donepezil—Alzheimer's disease	0.00261	0.00333	CcSEcCtD
Glycopyrrolate—Erectile dysfunction—Memantine—Alzheimer's disease	0.0026	0.00331	CcSEcCtD
Glycopyrrolate—Dysuria—Rivastigmine—Alzheimer's disease	0.00258	0.00329	CcSEcCtD
Glycopyrrolate—Agitation—Galantamine—Alzheimer's disease	0.00257	0.00327	CcSEcCtD
Glycopyrrolate—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.00256	0.00327	CcSEcCtD
Glycopyrrolate—Hyperglycaemia—Memantine—Alzheimer's disease	0.00254	0.00324	CcSEcCtD
Glycopyrrolate—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.00254	0.00324	CcSEcCtD
Glycopyrrolate—Pneumonia—Memantine—Alzheimer's disease	0.00253	0.00322	CcSEcCtD
Glycopyrrolate—Infestation NOS—Memantine—Alzheimer's disease	0.00251	0.0032	CcSEcCtD
Glycopyrrolate—Infestation—Memantine—Alzheimer's disease	0.00251	0.0032	CcSEcCtD
Glycopyrrolate—CHRM5—brain—Alzheimer's disease	0.00251	0.0426	CbGeAlD
Glycopyrrolate—Rhinitis—Donepezil—Alzheimer's disease	0.00249	0.00318	CcSEcCtD
Glycopyrrolate—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.00249	0.00317	CcSEcCtD
Glycopyrrolate—Pneumonia—Rivastigmine—Alzheimer's disease	0.00247	0.00315	CcSEcCtD
Glycopyrrolate—Hypoaesthesia—Donepezil—Alzheimer's disease	0.00247	0.00315	CcSEcCtD
Glycopyrrolate—Palpitations—Galantamine—Alzheimer's disease	0.00247	0.00315	CcSEcCtD
Glycopyrrolate—Drowsiness—Rivastigmine—Alzheimer's disease	0.00246	0.00314	CcSEcCtD
Glycopyrrolate—Infestation NOS—Rivastigmine—Alzheimer's disease	0.00246	0.00314	CcSEcCtD
Glycopyrrolate—Infestation—Rivastigmine—Alzheimer's disease	0.00246	0.00314	CcSEcCtD
Glycopyrrolate—Urinary tract disorder—Donepezil—Alzheimer's disease	0.00245	0.00313	CcSEcCtD
Glycopyrrolate—Urinary tract infection—Memantine—Alzheimer's disease	0.00244	0.00312	CcSEcCtD
Glycopyrrolate—Urethral disorder—Donepezil—Alzheimer's disease	0.00244	0.00311	CcSEcCtD
Glycopyrrolate—Convulsion—Galantamine—Alzheimer's disease	0.00242	0.00308	CcSEcCtD
Glycopyrrolate—Hypertension—Galantamine—Alzheimer's disease	0.00241	0.00307	CcSEcCtD
Glycopyrrolate—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.00239	0.00305	CcSEcCtD
Glycopyrrolate—Epistaxis—Memantine—Alzheimer's disease	0.00237	0.00302	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00236	0.00301	CcSEcCtD
Glycopyrrolate—Sinusitis—Memantine—Alzheimer's disease	0.00236	0.00301	CcSEcCtD
Glycopyrrolate—Sweating—Rivastigmine—Alzheimer's disease	0.00236	0.00301	CcSEcCtD
Glycopyrrolate—Dry mouth—Galantamine—Alzheimer's disease	0.00232	0.00296	CcSEcCtD
Glycopyrrolate—Epistaxis—Rivastigmine—Alzheimer's disease	0.00232	0.00296	CcSEcCtD
Glycopyrrolate—Sinusitis—Rivastigmine—Alzheimer's disease	0.00231	0.00294	CcSEcCtD
Glycopyrrolate—Confusional state—Galantamine—Alzheimer's disease	0.0023	0.00293	CcSEcCtD
Glycopyrrolate—Rhinitis—Memantine—Alzheimer's disease	0.00226	0.00288	CcSEcCtD
Glycopyrrolate—CHRM2—nervous system—Alzheimer's disease	0.00225	0.0383	CbGeAlD
Glycopyrrolate—Hypoaesthesia—Memantine—Alzheimer's disease	0.00225	0.00286	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Galantamine—Alzheimer's disease	0.00223	0.00285	CcSEcCtD
Glycopyrrolate—Urinary tract disorder—Memantine—Alzheimer's disease	0.00223	0.00284	CcSEcCtD
Glycopyrrolate—Tachycardia—Galantamine—Alzheimer's disease	0.00222	0.00283	CcSEcCtD
Glycopyrrolate—Connective tissue disorder—Memantine—Alzheimer's disease	0.00222	0.00283	CcSEcCtD
Glycopyrrolate—Rhinitis—Rivastigmine—Alzheimer's disease	0.00221	0.00282	CcSEcCtD
Glycopyrrolate—Skin disorder—Galantamine—Alzheimer's disease	0.00221	0.00282	CcSEcCtD
Glycopyrrolate—Urethral disorder—Memantine—Alzheimer's disease	0.00221	0.00282	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Galantamine—Alzheimer's disease	0.0022	0.00281	CcSEcCtD
Glycopyrrolate—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.0022	0.0028	CcSEcCtD
Glycopyrrolate—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.00218	0.00278	CcSEcCtD
Glycopyrrolate—Mental disorder—Donepezil—Alzheimer's disease	0.00218	0.00278	CcSEcCtD
Glycopyrrolate—CHRM2—central nervous system—Alzheimer's disease	0.00217	0.0368	CbGeAlD
Glycopyrrolate—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.00217	0.00277	CcSEcCtD
Glycopyrrolate—Urethral disorder—Rivastigmine—Alzheimer's disease	0.00216	0.00276	CcSEcCtD
Glycopyrrolate—Erythema—Donepezil—Alzheimer's disease	0.00216	0.00276	CcSEcCtD
Glycopyrrolate—Malnutrition—Donepezil—Alzheimer's disease	0.00216	0.00276	CcSEcCtD
Glycopyrrolate—Flatulence—Donepezil—Alzheimer's disease	0.00213	0.00272	CcSEcCtD
Glycopyrrolate—Hypotension—Galantamine—Alzheimer's disease	0.00213	0.00271	CcSEcCtD
Glycopyrrolate—Tension—Donepezil—Alzheimer's disease	0.00212	0.00271	CcSEcCtD
Glycopyrrolate—Dysgeusia—Donepezil—Alzheimer's disease	0.00212	0.0027	CcSEcCtD
Glycopyrrolate—Nervousness—Donepezil—Alzheimer's disease	0.0021	0.00268	CcSEcCtD
Glycopyrrolate—Cardiac disorder—Memantine—Alzheimer's disease	0.00209	0.00267	CcSEcCtD
Glycopyrrolate—Flushing—Memantine—Alzheimer's disease	0.00209	0.00267	CcSEcCtD
Glycopyrrolate—Insomnia—Galantamine—Alzheimer's disease	0.00206	0.00263	CcSEcCtD
Glycopyrrolate—CHRM1—nervous system—Alzheimer's disease	0.00205	0.0348	CbGeAlD
Glycopyrrolate—Flushing—Rivastigmine—Alzheimer's disease	0.00205	0.00261	CcSEcCtD
Glycopyrrolate—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.00205	0.00261	CcSEcCtD
Glycopyrrolate—Vision blurred—Donepezil—Alzheimer's disease	0.00204	0.0026	CcSEcCtD
Glycopyrrolate—Mediastinal disorder—Memantine—Alzheimer's disease	0.00203	0.00259	CcSEcCtD
Glycopyrrolate—Somnolence—Galantamine—Alzheimer's disease	0.00203	0.00258	CcSEcCtD
Glycopyrrolate—Dyspepsia—Galantamine—Alzheimer's disease	0.00201	0.00256	CcSEcCtD
Glycopyrrolate—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.00199	0.00254	CcSEcCtD
Glycopyrrolate—Agitation—Donepezil—Alzheimer's disease	0.00199	0.00253	CcSEcCtD
Glycopyrrolate—Mental disorder—Memantine—Alzheimer's disease	0.00198	0.00252	CcSEcCtD
Glycopyrrolate—CHRM1—central nervous system—Alzheimer's disease	0.00198	0.0335	CbGeAlD
Glycopyrrolate—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.00197	0.00251	CcSEcCtD
Glycopyrrolate—Malnutrition—Memantine—Alzheimer's disease	0.00196	0.0025	CcSEcCtD
Glycopyrrolate—Fatigue—Galantamine—Alzheimer's disease	0.00196	0.0025	CcSEcCtD
Glycopyrrolate—Constipation—Galantamine—Alzheimer's disease	0.00195	0.00248	CcSEcCtD
Glycopyrrolate—Flatulence—Memantine—Alzheimer's disease	0.00194	0.00247	CcSEcCtD
Glycopyrrolate—Mental disorder—Rivastigmine—Alzheimer's disease	0.00193	0.00247	CcSEcCtD
Glycopyrrolate—Tension—Memantine—Alzheimer's disease	0.00193	0.00246	CcSEcCtD
Glycopyrrolate—Dysgeusia—Memantine—Alzheimer's disease	0.00192	0.00245	CcSEcCtD
Glycopyrrolate—Malnutrition—Rivastigmine—Alzheimer's disease	0.00192	0.00245	CcSEcCtD
Glycopyrrolate—Erythema—Rivastigmine—Alzheimer's disease	0.00192	0.00245	CcSEcCtD
Glycopyrrolate—Nervousness—Memantine—Alzheimer's disease	0.00191	0.00243	CcSEcCtD
Glycopyrrolate—Flatulence—Rivastigmine—Alzheimer's disease	0.00189	0.00241	CcSEcCtD
Glycopyrrolate—Tension—Rivastigmine—Alzheimer's disease	0.00189	0.0024	CcSEcCtD
Glycopyrrolate—Dysgeusia—Rivastigmine—Alzheimer's disease	0.00188	0.0024	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Galantamine—Alzheimer's disease	0.00188	0.00239	CcSEcCtD
Glycopyrrolate—Convulsion—Donepezil—Alzheimer's disease	0.00187	0.00239	CcSEcCtD
Glycopyrrolate—Hypertension—Donepezil—Alzheimer's disease	0.00187	0.00238	CcSEcCtD
Glycopyrrolate—Nervousness—Rivastigmine—Alzheimer's disease	0.00187	0.00238	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.00186	0.00238	CcSEcCtD
Glycopyrrolate—Vision blurred—Memantine—Alzheimer's disease	0.00185	0.00236	CcSEcCtD
Glycopyrrolate—CHRM3—nervous system—Alzheimer's disease	0.00184	0.0312	CbGeAlD
Glycopyrrolate—Vision blurred—Rivastigmine—Alzheimer's disease	0.00181	0.00231	CcSEcCtD
Glycopyrrolate—Agitation—Memantine—Alzheimer's disease	0.00181	0.0023	CcSEcCtD
Glycopyrrolate—Dry mouth—Donepezil—Alzheimer's disease	0.0018	0.0023	CcSEcCtD
Glycopyrrolate—Abdominal pain—Galantamine—Alzheimer's disease	0.0018	0.0023	CcSEcCtD
Glycopyrrolate—Body temperature increased—Galantamine—Alzheimer's disease	0.0018	0.0023	CcSEcCtD
Glycopyrrolate—Confusional state—Donepezil—Alzheimer's disease	0.00178	0.00227	CcSEcCtD
Glycopyrrolate—CHRM3—central nervous system—Alzheimer's disease	0.00177	0.03	CbGeAlD
Glycopyrrolate—Agitation—Rivastigmine—Alzheimer's disease	0.00177	0.00225	CcSEcCtD
Glycopyrrolate—Oedema—Donepezil—Alzheimer's disease	0.00177	0.00225	CcSEcCtD
Glycopyrrolate—Infection—Donepezil—Alzheimer's disease	0.00175	0.00224	CcSEcCtD
Glycopyrrolate—Palpitations—Memantine—Alzheimer's disease	0.00174	0.00221	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Donepezil—Alzheimer's disease	0.00173	0.00221	CcSEcCtD
Glycopyrrolate—CHRM2—brain—Alzheimer's disease	0.00172	0.0293	CbGeAlD
Glycopyrrolate—Hyperhidrosis—Donepezil—Alzheimer's disease	0.00171	0.00218	CcSEcCtD
Glycopyrrolate—Convulsion—Memantine—Alzheimer's disease	0.0017	0.00217	CcSEcCtD
Glycopyrrolate—Palpitations—Rivastigmine—Alzheimer's disease	0.0017	0.00217	CcSEcCtD
Glycopyrrolate—Hypertension—Memantine—Alzheimer's disease	0.0017	0.00216	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Galantamine—Alzheimer's disease	0.00168	0.00214	CcSEcCtD
Glycopyrrolate—Convulsion—Rivastigmine—Alzheimer's disease	0.00167	0.00212	CcSEcCtD
Glycopyrrolate—Hypertension—Rivastigmine—Alzheimer's disease	0.00166	0.00212	CcSEcCtD
Glycopyrrolate—Hypotension—Donepezil—Alzheimer's disease	0.00165	0.0021	CcSEcCtD
Glycopyrrolate—Dry mouth—Memantine—Alzheimer's disease	0.00164	0.00209	CcSEcCtD
Glycopyrrolate—Asthenia—Galantamine—Alzheimer's disease	0.00163	0.00208	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.00162	0.00207	CcSEcCtD
Glycopyrrolate—Confusional state—Memantine—Alzheimer's disease	0.00162	0.00206	CcSEcCtD
Glycopyrrolate—Oedema—Memantine—Alzheimer's disease	0.0016	0.00204	CcSEcCtD
Glycopyrrolate—Dry mouth—Rivastigmine—Alzheimer's disease	0.0016	0.00204	CcSEcCtD
Glycopyrrolate—Insomnia—Donepezil—Alzheimer's disease	0.0016	0.00204	CcSEcCtD
Glycopyrrolate—Infection—Memantine—Alzheimer's disease	0.00159	0.00203	CcSEcCtD
Glycopyrrolate—Confusional state—Rivastigmine—Alzheimer's disease	0.00158	0.00202	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Memantine—Alzheimer's disease	0.00157	0.002	CcSEcCtD
Glycopyrrolate—Somnolence—Donepezil—Alzheimer's disease	0.00157	0.002	CcSEcCtD
Glycopyrrolate—Oedema—Rivastigmine—Alzheimer's disease	0.00157	0.002	CcSEcCtD
Glycopyrrolate—CHRM1—brain—Alzheimer's disease	0.00157	0.0266	CbGeAlD
Glycopyrrolate—Tachycardia—Memantine—Alzheimer's disease	0.00156	0.00199	CcSEcCtD
Glycopyrrolate—Infection—Rivastigmine—Alzheimer's disease	0.00156	0.00199	CcSEcCtD
Glycopyrrolate—Skin disorder—Memantine—Alzheimer's disease	0.00156	0.00199	CcSEcCtD
Glycopyrrolate—Dyspepsia—Donepezil—Alzheimer's disease	0.00155	0.00198	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Memantine—Alzheimer's disease	0.00155	0.00198	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.00154	0.00196	CcSEcCtD
Glycopyrrolate—Tachycardia—Rivastigmine—Alzheimer's disease	0.00153	0.00195	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.00152	0.00194	CcSEcCtD
Glycopyrrolate—Skin disorder—Rivastigmine—Alzheimer's disease	0.00152	0.00194	CcSEcCtD
Glycopyrrolate—Fatigue—Donepezil—Alzheimer's disease	0.00152	0.00194	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.00152	0.00193	CcSEcCtD
Glycopyrrolate—Constipation—Donepezil—Alzheimer's disease	0.00151	0.00192	CcSEcCtD
Glycopyrrolate—Pain—Donepezil—Alzheimer's disease	0.00151	0.00192	CcSEcCtD
Glycopyrrolate—Dizziness—Galantamine—Alzheimer's disease	0.00151	0.00192	CcSEcCtD
Glycopyrrolate—Hypotension—Memantine—Alzheimer's disease	0.0015	0.00191	CcSEcCtD
Glycopyrrolate—Hypotension—Rivastigmine—Alzheimer's disease	0.00147	0.00187	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Donepezil—Alzheimer's disease	0.00146	0.00186	CcSEcCtD
Glycopyrrolate—Insomnia—Memantine—Alzheimer's disease	0.00145	0.00185	CcSEcCtD
Glycopyrrolate—Vomiting—Galantamine—Alzheimer's disease	0.00145	0.00185	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.00144	0.00184	CcSEcCtD
Glycopyrrolate—Rash—Galantamine—Alzheimer's disease	0.00144	0.00183	CcSEcCtD
Glycopyrrolate—Dermatitis—Galantamine—Alzheimer's disease	0.00144	0.00183	CcSEcCtD
Glycopyrrolate—Headache—Galantamine—Alzheimer's disease	0.00143	0.00182	CcSEcCtD
Glycopyrrolate—Somnolence—Memantine—Alzheimer's disease	0.00143	0.00182	CcSEcCtD
Glycopyrrolate—Insomnia—Rivastigmine—Alzheimer's disease	0.00142	0.00181	CcSEcCtD
Glycopyrrolate—Dyspepsia—Memantine—Alzheimer's disease	0.00141	0.0018	CcSEcCtD
Glycopyrrolate—CHRM3—brain—Alzheimer's disease	0.0014	0.0238	CbGeAlD
Glycopyrrolate—Urticaria—Donepezil—Alzheimer's disease	0.0014	0.00179	CcSEcCtD
Glycopyrrolate—Abdominal pain—Donepezil—Alzheimer's disease	0.0014	0.00178	CcSEcCtD
Glycopyrrolate—Body temperature increased—Donepezil—Alzheimer's disease	0.0014	0.00178	CcSEcCtD
Glycopyrrolate—Somnolence—Rivastigmine—Alzheimer's disease	0.00139	0.00178	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.00138	0.00176	CcSEcCtD
Glycopyrrolate—Fatigue—Memantine—Alzheimer's disease	0.00138	0.00176	CcSEcCtD
Glycopyrrolate—Dyspepsia—Rivastigmine—Alzheimer's disease	0.00138	0.00176	CcSEcCtD
Glycopyrrolate—Pain—Memantine—Alzheimer's disease	0.00137	0.00175	CcSEcCtD
Glycopyrrolate—Constipation—Memantine—Alzheimer's disease	0.00137	0.00175	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.00135	0.00173	CcSEcCtD
Glycopyrrolate—Nausea—Galantamine—Alzheimer's disease	0.00135	0.00173	CcSEcCtD
Glycopyrrolate—Fatigue—Rivastigmine—Alzheimer's disease	0.00135	0.00172	CcSEcCtD
Glycopyrrolate—Pain—Rivastigmine—Alzheimer's disease	0.00134	0.00171	CcSEcCtD
Glycopyrrolate—Constipation—Rivastigmine—Alzheimer's disease	0.00134	0.00171	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Memantine—Alzheimer's disease	0.00132	0.00168	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Memantine—Alzheimer's disease	0.00131	0.00167	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Donepezil—Alzheimer's disease	0.0013	0.00166	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.00129	0.00165	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.00128	0.00164	CcSEcCtD
Glycopyrrolate—Urticaria—Memantine—Alzheimer's disease	0.00127	0.00162	CcSEcCtD
Glycopyrrolate—Abdominal pain—Memantine—Alzheimer's disease	0.00127	0.00162	CcSEcCtD
Glycopyrrolate—Body temperature increased—Memantine—Alzheimer's disease	0.00127	0.00162	CcSEcCtD
Glycopyrrolate—Asthenia—Donepezil—Alzheimer's disease	0.00127	0.00162	CcSEcCtD
Glycopyrrolate—Pruritus—Donepezil—Alzheimer's disease	0.00125	0.00159	CcSEcCtD
Glycopyrrolate—Urticaria—Rivastigmine—Alzheimer's disease	0.00125	0.00159	CcSEcCtD
Glycopyrrolate—Body temperature increased—Rivastigmine—Alzheimer's disease	0.00124	0.00158	CcSEcCtD
Glycopyrrolate—Abdominal pain—Rivastigmine—Alzheimer's disease	0.00124	0.00158	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Memantine—Alzheimer's disease	0.00118	0.00151	CcSEcCtD
Glycopyrrolate—Dizziness—Donepezil—Alzheimer's disease	0.00117	0.00149	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.00116	0.00147	CcSEcCtD
Glycopyrrolate—Asthenia—Memantine—Alzheimer's disease	0.00115	0.00147	CcSEcCtD
Glycopyrrolate—Pruritus—Memantine—Alzheimer's disease	0.00113	0.00145	CcSEcCtD
Glycopyrrolate—Asthenia—Rivastigmine—Alzheimer's disease	0.00113	0.00143	CcSEcCtD
Glycopyrrolate—Vomiting—Donepezil—Alzheimer's disease	0.00112	0.00143	CcSEcCtD
Glycopyrrolate—Rash—Donepezil—Alzheimer's disease	0.00111	0.00142	CcSEcCtD
Glycopyrrolate—Dermatitis—Donepezil—Alzheimer's disease	0.00111	0.00142	CcSEcCtD
Glycopyrrolate—Pruritus—Rivastigmine—Alzheimer's disease	0.00111	0.00141	CcSEcCtD
Glycopyrrolate—Headache—Donepezil—Alzheimer's disease	0.00111	0.00141	CcSEcCtD
Glycopyrrolate—Dizziness—Memantine—Alzheimer's disease	0.00106	0.00135	CcSEcCtD
Glycopyrrolate—Nausea—Donepezil—Alzheimer's disease	0.00105	0.00134	CcSEcCtD
Glycopyrrolate—Dizziness—Rivastigmine—Alzheimer's disease	0.00104	0.00132	CcSEcCtD
Glycopyrrolate—Vomiting—Memantine—Alzheimer's disease	0.00102	0.0013	CcSEcCtD
Glycopyrrolate—Rash—Memantine—Alzheimer's disease	0.00101	0.00129	CcSEcCtD
Glycopyrrolate—Dermatitis—Memantine—Alzheimer's disease	0.00101	0.00129	CcSEcCtD
Glycopyrrolate—Headache—Memantine—Alzheimer's disease	0.001	0.00128	CcSEcCtD
Glycopyrrolate—Vomiting—Rivastigmine—Alzheimer's disease	0.000997	0.00127	CcSEcCtD
Glycopyrrolate—Rash—Rivastigmine—Alzheimer's disease	0.000989	0.00126	CcSEcCtD
Glycopyrrolate—Dermatitis—Rivastigmine—Alzheimer's disease	0.000988	0.00126	CcSEcCtD
Glycopyrrolate—Headache—Rivastigmine—Alzheimer's disease	0.000983	0.00125	CcSEcCtD
Glycopyrrolate—Nausea—Memantine—Alzheimer's disease	0.000952	0.00121	CcSEcCtD
Glycopyrrolate—Nausea—Rivastigmine—Alzheimer's disease	0.000932	0.00119	CcSEcCtD
Glycopyrrolate—Trospium—CYP2D6—Alzheimer's disease	0.000639	0.524	CrCbGaD
Glycopyrrolate—Oxybutynin—CYP2D6—Alzheimer's disease	0.00058	0.476	CrCbGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—CREB1—Alzheimer's disease	6.51e-05	0.000419	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—CCR5—Alzheimer's disease	6.46e-05	0.000415	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—CCR5—Alzheimer's disease	6.44e-05	0.000414	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—ADAM10—Alzheimer's disease	6.4e-05	0.000411	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—CCR5—Alzheimer's disease	6.37e-05	0.00041	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—CCL2—Alzheimer's disease	6.37e-05	0.00041	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—HTR2A—Alzheimer's disease	6.32e-05	0.000406	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—S100B—Alzheimer's disease	6.32e-05	0.000406	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—HTR2A—Alzheimer's disease	6.3e-05	0.000405	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—BCHE—Alzheimer's disease	6.24e-05	0.000402	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—HTR2A—Alzheimer's disease	6.24e-05	0.000401	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—PRKCG—Alzheimer's disease	6.19e-05	0.000398	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—PRKCG—Alzheimer's disease	6.17e-05	0.000397	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—NPY—Alzheimer's disease	6.16e-05	0.000396	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—NPY—Alzheimer's disease	6.14e-05	0.000395	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—IAPP—Alzheimer's disease	6.12e-05	0.000394	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—PRKCG—Alzheimer's disease	6.11e-05	0.000393	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—IAPP—Alzheimer's disease	6.1e-05	0.000392	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—NPY—Alzheimer's disease	6.08e-05	0.000391	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—S100B—Alzheimer's disease	6.05e-05	0.000389	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—IAPP—Alzheimer's disease	6.04e-05	0.000389	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—IGF2—Alzheimer's disease	6.01e-05	0.000387	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CRH—Alzheimer's disease	5.94e-05	0.000382	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CRH—Alzheimer's disease	5.92e-05	0.000381	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PLCB1—Alzheimer's disease	5.89e-05	0.000379	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CRH—Alzheimer's disease	5.87e-05	0.000377	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—CCR5—Alzheimer's disease	5.86e-05	0.000377	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—CCR5—Alzheimer's disease	5.84e-05	0.000376	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—IGF1R—Alzheimer's disease	5.81e-05	0.000374	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—CCR5—Alzheimer's disease	5.79e-05	0.000372	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—IGF2—Alzheimer's disease	5.76e-05	0.00037	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—HTR2A—Alzheimer's disease	5.74e-05	0.000369	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—HTR2A—Alzheimer's disease	5.72e-05	0.000368	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—ABCA1—Alzheimer's disease	5.71e-05	0.000367	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—HTR2A—Alzheimer's disease	5.66e-05	0.000364	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—NPS—Alzheimer's disease	5.63e-05	0.000362	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—NPS—Alzheimer's disease	5.62e-05	0.000361	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PPP3CA—Alzheimer's disease	5.61e-05	0.000361	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PPP3CA—Alzheimer's disease	5.59e-05	0.000359	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—LPL—Alzheimer's disease	5.57e-05	0.000359	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—IGF1R—Alzheimer's disease	5.57e-05	0.000358	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—NPS—Alzheimer's disease	5.56e-05	0.000358	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—F2—Alzheimer's disease	5.54e-05	0.000356	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PPP3CA—Alzheimer's disease	5.53e-05	0.000356	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—MEF2C—Alzheimer's disease	5.52e-05	0.000355	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PTK2B—Alzheimer's disease	5.52e-05	0.000355	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—F2—Alzheimer's disease	5.52e-05	0.000355	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PTK2B—Alzheimer's disease	5.51e-05	0.000354	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—F2—Alzheimer's disease	5.47e-05	0.000352	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PTK2B—Alzheimer's disease	5.45e-05	0.000351	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—PRKCG—Alzheimer's disease	5.42e-05	0.000349	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—SST—Alzheimer's disease	5.37e-05	0.000346	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—GAB2—Alzheimer's disease	5.37e-05	0.000346	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—NTRK2—Alzheimer's disease	5.37e-05	0.000346	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—GAB2—Alzheimer's disease	5.36e-05	0.000345	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—NTRK2—Alzheimer's disease	5.36e-05	0.000345	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—SST—Alzheimer's disease	5.36e-05	0.000345	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—CALM1—Alzheimer's disease	5.35e-05	0.000344	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—LPL—Alzheimer's disease	5.34e-05	0.000343	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—CALM1—Alzheimer's disease	5.34e-05	0.000343	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—GSK3A—Alzheimer's disease	5.33e-05	0.000343	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—GSK3A—Alzheimer's disease	5.31e-05	0.000342	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—GAB2—Alzheimer's disease	5.31e-05	0.000341	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—SST—Alzheimer's disease	5.31e-05	0.000341	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—NTRK2—Alzheimer's disease	5.31e-05	0.000341	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—MEF2C—Alzheimer's disease	5.29e-05	0.00034	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—CALM1—Alzheimer's disease	5.28e-05	0.00034	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—NGF—Alzheimer's disease	5.28e-05	0.00034	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—GSK3A—Alzheimer's disease	5.26e-05	0.000338	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—APP—Alzheimer's disease	5.24e-05	0.000337	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—APP—Alzheimer's disease	5.22e-05	0.000336	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—PRKCG—Alzheimer's disease	5.19e-05	0.000334	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—APP—Alzheimer's disease	5.17e-05	0.000333	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CCR5—Alzheimer's disease	5.14e-05	0.00033	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—NGF—Alzheimer's disease	5.06e-05	0.000325	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—F2—Alzheimer's disease	5.03e-05	0.000323	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—HTR2A—Alzheimer's disease	5.03e-05	0.000323	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—F2—Alzheimer's disease	5.01e-05	0.000322	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—F2—Alzheimer's disease	4.97e-05	0.000319	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PLCB1—Alzheimer's disease	4.94e-05	0.000318	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PLCB1—Alzheimer's disease	4.93e-05	0.000317	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PPARGC1A—Alzheimer's disease	4.92e-05	0.000317	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CCR5—Alzheimer's disease	4.92e-05	0.000316	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—HMOX1—Alzheimer's disease	4.9e-05	0.000315	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PLCB1—Alzheimer's disease	4.88e-05	0.000314	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—HTR2A—Alzheimer's disease	4.81e-05	0.00031	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CALM1—Alzheimer's disease	4.69e-05	0.000302	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—APOE—Alzheimer's disease	4.67e-05	0.000301	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—LEP—Alzheimer's disease	4.67e-05	0.000301	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CAV1—Alzheimer's disease	4.63e-05	0.000298	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—NGFR—Alzheimer's disease	4.61e-05	0.000297	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—NGFR—Alzheimer's disease	4.6e-05	0.000296	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—CREB1—Alzheimer's disease	4.58e-05	0.000295	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—CREB1—Alzheimer's disease	4.57e-05	0.000294	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—NGFR—Alzheimer's disease	4.55e-05	0.000293	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—CREB1—Alzheimer's disease	4.52e-05	0.000291	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—ADAM10—Alzheimer's disease	4.5e-05	0.00029	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CALM1—Alzheimer's disease	4.49e-05	0.000289	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—ADAM10—Alzheimer's disease	4.49e-05	0.000289	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—CCL2—Alzheimer's disease	4.48e-05	0.000288	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—LPL—Alzheimer's disease	4.48e-05	0.000288	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—APOE—Alzheimer's disease	4.47e-05	0.000288	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—LEP—Alzheimer's disease	4.47e-05	0.000288	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—CCL2—Alzheimer's disease	4.47e-05	0.000287	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—ESR1—Alzheimer's disease	4.46e-05	0.000287	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—ADAM10—Alzheimer's disease	4.45e-05	0.000286	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CAV1—Alzheimer's disease	4.43e-05	0.000285	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—CCL2—Alzheimer's disease	4.43e-05	0.000285	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—F2—Alzheimer's disease	4.41e-05	0.000283	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—NOTCH1—Alzheimer's disease	4.31e-05	0.000277	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—ESR1—Alzheimer's disease	4.27e-05	0.000275	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—S100B—Alzheimer's disease	4.26e-05	0.000274	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—S100B—Alzheimer's disease	4.25e-05	0.000273	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—F2—Alzheimer's disease	4.22e-05	0.000271	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—S100B—Alzheimer's disease	4.2e-05	0.00027	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—NOTCH1—Alzheimer's disease	4.13e-05	0.000266	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—IGF2—Alzheimer's disease	4.06e-05	0.000261	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—GSK3B—Alzheimer's disease	4.05e-05	0.00026	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—IGF2—Alzheimer's disease	4.04e-05	0.00026	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—MTHFR—Alzheimer's disease	4.03e-05	0.000259	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CREB1—Alzheimer's disease	4.01e-05	0.000258	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—IGF2—Alzheimer's disease	4e-05	0.000257	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—INS—Alzheimer's disease	3.99e-05	0.000257	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CCL2—Alzheimer's disease	3.93e-05	0.000253	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—IGF1R—Alzheimer's disease	3.92e-05	0.000252	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—IGF1R—Alzheimer's disease	3.91e-05	0.000251	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—GSK3B—Alzheimer's disease	3.88e-05	0.000249	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—IGF1R—Alzheimer's disease	3.87e-05	0.000249	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—IGF1—Alzheimer's disease	3.86e-05	0.000248	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CREB1—Alzheimer's disease	3.84e-05	0.000247	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—INS—Alzheimer's disease	3.82e-05	0.000246	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—CALM1—Alzheimer's disease	3.77e-05	0.000242	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CCL2—Alzheimer's disease	3.76e-05	0.000242	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—LPL—Alzheimer's disease	3.76e-05	0.000242	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—APOE—Alzheimer's disease	3.76e-05	0.000242	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—LPL—Alzheimer's disease	3.75e-05	0.000241	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—MEF2C—Alzheimer's disease	3.73e-05	0.00024	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—CAV1—Alzheimer's disease	3.72e-05	0.000239	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—MEF2C—Alzheimer's disease	3.71e-05	0.000239	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—LPL—Alzheimer's disease	3.71e-05	0.000239	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—IGF1—Alzheimer's disease	3.7e-05	0.000238	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—MEF2C—Alzheimer's disease	3.68e-05	0.000237	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PRKCG—Alzheimer's disease	3.65e-05	0.000235	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PRKCG—Alzheimer's disease	3.64e-05	0.000234	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PRKCG—Alzheimer's disease	3.61e-05	0.000232	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—NGF—Alzheimer's disease	3.56e-05	0.000229	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—NGF—Alzheimer's disease	3.55e-05	0.000228	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—NGF—Alzheimer's disease	3.51e-05	0.000226	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—NOS3—Alzheimer's disease	3.5e-05	0.000225	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CCR5—Alzheimer's disease	3.46e-05	0.000223	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CCR5—Alzheimer's disease	3.45e-05	0.000222	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CCR5—Alzheimer's disease	3.42e-05	0.00022	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—HTR2A—Alzheimer's disease	3.39e-05	0.000218	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—HTR2A—Alzheimer's disease	3.38e-05	0.000217	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—NOS3—Alzheimer's disease	3.35e-05	0.000216	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—HTR2A—Alzheimer's disease	3.35e-05	0.000215	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PPARG—Alzheimer's disease	3.27e-05	0.00021	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—INS—Alzheimer's disease	3.21e-05	0.000206	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CALM1—Alzheimer's disease	3.16e-05	0.000203	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CALM1—Alzheimer's disease	3.15e-05	0.000203	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—LEP—Alzheimer's disease	3.15e-05	0.000203	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—APOE—Alzheimer's disease	3.15e-05	0.000203	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—APOE—Alzheimer's disease	3.14e-05	0.000202	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—LEP—Alzheimer's disease	3.14e-05	0.000202	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CAV1—Alzheimer's disease	3.12e-05	0.000201	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CALM1—Alzheimer's disease	3.12e-05	0.000201	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CAV1—Alzheimer's disease	3.11e-05	0.0002	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—LEP—Alzheimer's disease	3.11e-05	0.0002	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—APOE—Alzheimer's disease	3.11e-05	0.0002	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CAV1—Alzheimer's disease	3.08e-05	0.000198	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—ESR1—Alzheimer's disease	3.01e-05	0.000193	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—AKT1—Alzheimer's disease	3e-05	0.000193	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—ESR1—Alzheimer's disease	3e-05	0.000193	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CASP3—Alzheimer's disease	2.97e-05	0.000191	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—F2—Alzheimer's disease	2.97e-05	0.000191	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—ESR1—Alzheimer's disease	2.97e-05	0.000191	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—F2—Alzheimer's disease	2.96e-05	0.00019	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—IL6—Alzheimer's disease	2.95e-05	0.00019	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—F2—Alzheimer's disease	2.93e-05	0.000189	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—NOTCH1—Alzheimer's disease	2.91e-05	0.000187	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—NOTCH1—Alzheimer's disease	2.9e-05	0.000186	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—AKT1—Alzheimer's disease	2.87e-05	0.000185	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—NOTCH1—Alzheimer's disease	2.87e-05	0.000185	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CASP3—Alzheimer's disease	2.85e-05	0.000183	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—IL6—Alzheimer's disease	2.83e-05	0.000182	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—NOS3—Alzheimer's disease	2.81e-05	0.000181	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—MAPK8—Alzheimer's disease	2.73e-05	0.000176	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—GSK3B—Alzheimer's disease	2.73e-05	0.000175	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—AKT1—Alzheimer's disease	2.72e-05	0.000175	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—GSK3B—Alzheimer's disease	2.72e-05	0.000175	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CREB1—Alzheimer's disease	2.71e-05	0.000174	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CREB1—Alzheimer's disease	2.7e-05	0.000174	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—GSK3B—Alzheimer's disease	2.69e-05	0.000173	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—INS—Alzheimer's disease	2.69e-05	0.000173	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—INS—Alzheimer's disease	2.68e-05	0.000173	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CREB1—Alzheimer's disease	2.67e-05	0.000172	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—INS—Alzheimer's disease	2.66e-05	0.000171	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CCL2—Alzheimer's disease	2.65e-05	0.00017	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CCL2—Alzheimer's disease	2.64e-05	0.00017	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—MAPK8—Alzheimer's disease	2.62e-05	0.000168	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CCL2—Alzheimer's disease	2.61e-05	0.000168	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—AKT1—Alzheimer's disease	2.61e-05	0.000168	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—IGF1—Alzheimer's disease	2.6e-05	0.000167	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—IGF1—Alzheimer's disease	2.6e-05	0.000167	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PTGS2—Alzheimer's disease	2.57e-05	0.000166	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—IGF1—Alzheimer's disease	2.57e-05	0.000165	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—VEGFA—Alzheimer's disease	2.52e-05	0.000162	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—VEGFA—Alzheimer's disease	2.42e-05	0.000155	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—NOS3—Alzheimer's disease	2.36e-05	0.000152	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—NOS3—Alzheimer's disease	2.35e-05	0.000151	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—NOS3—Alzheimer's disease	2.33e-05	0.00015	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—TGFB1—Alzheimer's disease	2.31e-05	0.000149	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—TGFB1—Alzheimer's disease	2.22e-05	0.000143	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—AKT1—Alzheimer's disease	2.02e-05	0.00013	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—AKT1—Alzheimer's disease	2.02e-05	0.00013	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CASP3—Alzheimer's disease	2e-05	0.000129	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CASP3—Alzheimer's disease	2e-05	0.000128	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—AKT1—Alzheimer's disease	2e-05	0.000128	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—IL6—Alzheimer's disease	1.99e-05	0.000128	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—IL6—Alzheimer's disease	1.98e-05	0.000128	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CASP3—Alzheimer's disease	1.98e-05	0.000127	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—IL6—Alzheimer's disease	1.97e-05	0.000126	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—TP53—Alzheimer's disease	1.91e-05	0.000123	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—MAPK8—Alzheimer's disease	1.84e-05	0.000118	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—AKT1—Alzheimer's disease	1.84e-05	0.000118	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—MAPK8—Alzheimer's disease	1.84e-05	0.000118	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—AKT1—Alzheimer's disease	1.83e-05	0.000118	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—TP53—Alzheimer's disease	1.82e-05	0.000117	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—MAPK8—Alzheimer's disease	1.82e-05	0.000117	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—AKT1—Alzheimer's disease	1.81e-05	0.000117	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—IL6—Alzheimer's disease	1.74e-05	0.000112	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—VEGFA—Alzheimer's disease	1.7e-05	0.000109	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—VEGFA—Alzheimer's disease	1.7e-05	0.000109	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—VEGFA—Alzheimer's disease	1.68e-05	0.000108	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—IL6—Alzheimer's disease	1.67e-05	0.000107	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—AKT1—Alzheimer's disease	1.61e-05	0.000103	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—TGFB1—Alzheimer's disease	1.56e-05	0.0001	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—TGFB1—Alzheimer's disease	1.56e-05	0.0001	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—AKT1—Alzheimer's disease	1.54e-05	9.91e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—TGFB1—Alzheimer's disease	1.54e-05	9.91e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—AKT1—Alzheimer's disease	1.29e-05	8.32e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—TP53—Alzheimer's disease	1.28e-05	8.26e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—TP53—Alzheimer's disease	1.28e-05	8.24e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—TP53—Alzheimer's disease	1.27e-05	8.16e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—IL6—Alzheimer's disease	1.18e-05	7.56e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—IL6—Alzheimer's disease	1.17e-05	7.54e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—IL6—Alzheimer's disease	1.16e-05	7.47e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—AKT1—Alzheimer's disease	1.09e-05	6.98e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—AKT1—Alzheimer's disease	1.08e-05	6.96e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—AKT1—Alzheimer's disease	1.07e-05	6.89e-05	CbGpPWpGaD
